Thermo Fisher Scientific Inc.
TMO
$492.60
$3.110.64%
NYSE
| 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.04% | 0.96% | 0.05% | -2.42% | -2.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.05% | 0.96% | 0.05% | -2.42% | -2.71% |
| Cost of Revenue | 1.35% | -0.53% | -2.07% | -3.78% | -4.33% |
| Gross Profit | 3.06% | 3.14% | 3.22% | -0.39% | -0.26% |
| SG&A Expenses | -0.30% | 0.72% | 2.55% | 0.57% | -2.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2,900.00% | 2,900.00% | 2,900.00% | -- | -- |
| Total Operating Expenses | 1.26% | 0.10% | -0.67% | -2.77% | -3.95% |
| Operating Income | 5.67% | 4.98% | 3.45% | -0.77% | 3.49% |
| Income Before Tax | 3.51% | 7.32% | 12.17% | 8.26% | 12.51% |
| Income Tax Expenses | -26.72% | -9.06% | 131.69% | 97.84% | 97.02% |
| Earnings from Continuing Operations | 6.42% | 8.74% | 6.47% | 3.36% | 8.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | -110.26% | -110.00% | -22.22% | 780.00% |
| Net Income | 5.84% | 7.97% | 5.69% | 3.28% | 8.74% |
| EBIT | 5.67% | 4.98% | 3.45% | -0.77% | 3.49% |
| EBITDA | -0.18% | -0.31% | -0.37% | -2.50% | 1.62% |
| EPS Basic | 7.03% | 9.19% | 6.87% | 4.36% | 10.02% |
| Normalized Basic EPS | 6.96% | 6.08% | 7.00% | 2.52% | 8.81% |
| EPS Diluted | 7.24% | 9.36% | 6.99% | 4.69% | 10.37% |
| Normalized Diluted EPS | 7.10% | 6.21% | 7.06% | 2.65% | 9.01% |
| Average Basic Shares Outstanding | -1.11% | -1.10% | -1.10% | -1.03% | -1.16% |
| Average Diluted Shares Outstanding | -1.23% | -1.23% | -1.16% | -1.16% | -1.34% |
| Dividend Per Share | 10.81% | 11.11% | 11.43% | 12.59% | 13.85% |
| Payout Ratio | 0.04% | 0.02% | 0.05% | 0.10% | 0.05% |